-
by
Ben Crnic
Breaking News
Now that the new COVID-19 vaccine is available in New York, Gov. Kathy Hochul is urging residents to get their updated shots ahead of this year's respiratory virus illness season. Related story - COVID-19: New XEC Strain 'Just Getting Started' Sparks Concern Amid Summer Wave Of US CasesIn an announcement this week, Hochul encouraged eligible New Yorkers to get the new Food and Drug ...
-
by
Joe Lombardi
National Interest
The US Food and Drug Administration has just approved new COVID-19 vaccines.It marks the third time the vaccines from Pfizer and Moderna have been updated to match circulating strains since the original shot.The shots should be available within days, the FDA said in making the announcement Thursday afternoon, Aug. 22.The new vaccines have been updated with a formula to more closely ...
-
by
Ben Crnic
Breaking News
New York Gov. Kathy Hochul is urging residents to receive a new, updated COVID-19 vaccine meant to target a mutated variant of the virus. The new vaccine, approved by the federal Centers for Disease Control and Prevention on Tuesday, Sept. 12, and previously authorized by the federal Food and Drug Administration, is meant to target a subvariant of Omicron called XBB.1.5, Hochul ...
-
by
Michael Mashburn
Breaking News
Health officials are one step closer to rolling out updated COVID-19 vaccines just in time for a rise in cases heading into the fall and winter months.The US Food and Drug Administration (FDA) approved new vaccines on Monday, Sept. 11, that are meant to better target currently circulating COVID-19 variants and provide better protection against hospitalization and death, the agency ...
-
by
Mac Bullock
Breaking News
Researchers at the University of Pennsylvania are seeing "promising results" in the early testing phases of an experimental mRNA-based influenza vaccine. In a statement on Friday, Nov. 25, Penn Medicine scientists said initial models suggest the new vaccine "provided broad protection" against "otherwise lethal" strains of the flu. The experimental jab is powered by the same mRNA ...
-
by
Nicole Valinote
Breaking News
The Food and Drug Administration has authorized the use of updated COVID-19 booster shots targeting the Omicron variant for younger children.The FDA announced the amended emergency use authorization of the bivalent Moderna and Pfizer booster vaccines on Wednesday, Oct. 12.Today, FDA amended the EUA of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, ...
-
by
Cecilia Levine
Your Community
The popular Amazon Prime show "The Marvelous Mrs. Maisel" is seeking young women to play extras in an upcoming episode shooting in New York City.Actors must be at least 18 years old and will be portraying "upscale society women and uptown girls" in a 1960s Bryn Mawr college reunion scene with Midge Maisel.Here are the requirements:Hair: No fashion colors. No wigs. No weaves. No braids. ...
-
by
Michael Mashburn
Breaking News
It’s time to roll up your sleeve and get another COVID-19 vaccine.On Wednesday, Aug. 31, the US Food and Drug Administration (FDA) approved updated versions of COVID booster shots made by Pfizer and Moderna that target the highly contagious BA.5 Omicron subvariant. The updated vaccine boosters are designed to give people broad protection against COVID and can help protect against severe ...
-
by
Jillian Pikora
Breaking News
President Joe Biden tested positive for COVID-19 on Thursday, July 21, according to White House Press Secretary Karine Jean-Pierre.He was experiencing “mild symptoms” and has begun taking Paxlovid, the Pfizer antiviral drug designed to reduce the severity of the disease.His trip to Wilkes University in Wilkes-Barre, Pennsylvania has evidently been canceled as he “will isolate at the ...
-
by
Zak Failla
Breaking News
Federal health officials are moving closer to authorizing COVID-19 vaccines for the youngest Americans.The US Food and Drug Administration (FDA) voted on Wednesday, June 15 to recommend authorizing both the Moderna and Pfizer COVID-19 vaccines for children between the ages of 6 months and 5 years old. On Wednesday, the agency’s independent panel of experts voted to recommend the ...
-
by
Zak Failla
Breaking News
Federal health officials are moving closer to authorizing COVID-19 vaccines for the youngest Americans.The US Food and Drug Administration (FDA) voted on Wednesday, June 15 to recommend authorizing both the Moderna and Pfizer COVID-19 vaccines for children between the ages of 6 months and 5 years old. On Wednesday, the agency’s independent panel of experts voted to recommend the ...
-
by
Zak Failla
Your Community
A pop-up COVID-19 clinic has been scheduled in one of Westchester’s largest communities.#VaxUpWestchester announced that it is teaming up with the Mount Vernon Neighborhood Health Center and RXR Realty to provide COVID-19 vaccinations and boosters for all eligible residents in the region.The event has been scheduled for 10 a.m. through 4 p.m. on Saturday, April 30, at the Food Bazaar on ...
-
by
Michael Mashburn
Breaking News
Health officials in Albany County are calling for a return to mask wearing amid a rise in COVID-19 cases in the area.In a public health advisory issued Monday, April 25, the Albany County Department of Health said it “strongly recommends” all residents, regardless of vaccination status, wear masks in indoor public spaces, including private businesses.The advisory follows a nearly 40% ...
-
by
Joe Lombardi
On Your Side
Pfizer has issued a recall for blood pressure pills that were distributed across the United States due to the presence of an organic compound it said could increase the risk of cancer.The five lots of Accupril (Quinapril HCl) tablets distributed by Pfizer to the patient level due to the presence of a nitrosamine, Nnitroso-quinapril, observed in recent testing above the Acceptable Daily ...
-
by
Kathy Reakes
On Your Side
Stop & Shop has begun offering two approved COVID-19 antiviral medicines, Pfizer's Paxlovid and Merck's Molnupiravir at its 55 New York pharmacies.The mega-supermarket chain made the announcement on Thursday, April 7, that the drugs would be available at no cost with a valid prescription from a health care provider.The COVID-19 anti-viral medication Molnupiravir can be prescribed to ...
-
by
Zak Failla
Breaking News
Federal health officials authorized a second booster shot of both the Pfizer and Moderna COVID-19 vaccines for older Americans.On Tuesday, March 29, the Food and Drug Administration (FDA) announced that a second shot has been approved for Americans who are 50 and older once four months have passed since their initial booster.With the FDA's approval, the decision now falls on Dr. ...
-
by
Nicole Valinote
Breaking News
The United States Food & Drug Administration is expected to authorize a second COVID-19 booster shot for some Americans within the next few days, according to multiple reports.CNN reported on Saturday, March 26, that sources said the FDA plans to authorize the additional booster shot for people ages 50 and older in the coming days.An anonymous official told The Washington Post that ...
-
by
Zak Failla
On Your Side
Pfizer announced a nationwide recall of blood pressure medication that could potentially contain cancer-causing carcinogens.The pharmaceutical giant announced that it was recalling certain lots of the blood pressure drug Accuretic and two authorized cheaper versions of the drug due to the presence of elevated levels of a nitrosamine, an impurity that could cause cancer.“Nitrosamines are ...
-
by
Zak Failla
Breaking News
Though the COVID-19 case numbers across the country have either plateaued or are showing improvement, Moderna is now seeking federal approval to administer a second booster shot for adults.Moderna is seeking an amendment of the US Food and Drug Administration’s emergency use authorization for its COVID-19 vaccine to allow for a fourth vaccine to adults 18 and older who have gotten an ...
-
by
Jerry DeMarco
Breaking News
TRIBUTE: The holiday season at the Emerson Fire Department won't be the same without Mark Brackenbury. Little else in town will be, either.The lifelong firefighter died peacefully at his Jersey Shore home surrounded by loved ones on Sunday, March 13, following a battle with cancer. He was 57.A Queens native, Brackenbury earned bachelor's and master's degrees from Stevens Institute of ...
-
by
Joe Lombardi
Breaking News
Warning that "many variants are coming," the chairman and chief executive officer of Pfizer says a fourth dose of the COVID-19 -- a second booster shot -- will be needed.Appearing on CBS-TV's "Face the Nation" on Sunday, March 13, Dr. Albert Bourla was asked if a COVID booster shot could become recommended each fall - similar to a flu shot."I think so," Bourla responded. "And I think ...
-
by
Zak Failla
Breaking News
Hundreds of Connecticut residents who recently received a COVID-19 vaccine may have to come back for seconds after a health department improperly stored the doses.The New Haven Department of Health announced on Friday, Feb. 11 that approximately 650 individuals over the age of 12 who received a Pfizer vaccine from the site on Meadow Road may have received doses that were stored for too ...
-
by
Zak Failla
Breaking News
Federal health officials delayed a planned public meeting to review Pfizer’s COVID-19 vaccine for children under five.Citing the need to see more data as part of its rolling application process, the Food and Drug Administration (FDA) announced on Friday, Feb. 11 that it would be delaying the planned meeting, raising questions about how soon children should get the COVID-19 shot.The ...
-
by
Zak Failla
Breaking News
The only Johnson & Johnson facility currently making viable batches of the company's one-dose COVID-19 vaccine has temporarily halted its production, according to a new report.According to The New York Times, Johnson & Johnson has stopped production of its current vaccine, potentially to create a more profitable version aimed at other viruses.With production on hold at its Dutch ...
-
by
Zak Failla
Breaking News
New York-based Pfizer and its European partner BioNTech has requested that the Food and Drug Administration (FDA) expand the use of its COVID-19 vaccine to include children between the ages of 6 months and 5 years old, officials announced.On Tuesday, Feb. 1, citing a host of clinical trials, the pharmaceutical company announced it is seeking emergency use authorization (EUA) to admit ...
-
by
Zak Failla
Breaking News
Federal officials have granted full approval to Moderna’s COVID-19 vaccine following its authorization last year for emergency use.On Monday, Jan. 31, the Food and Drug Administration (FDA) announced that Moderna’s vaccine has been granted its full approval, joining the Pfizer shot which was authorized months ago.The move comes after tens of millions of doses of the Moderna vaccine have ...
-
by
Nicole Valinote
On Your Side
New York-based Pfizer and its European partner BioNTech have launched a clinical study to evaluate a COVID-19 vaccine that specifically targets the Omicron variant.The study will evaluate the safety and efficacy of an Omicron-based vaccine among healthy adults ages 18 through 55, Pfizer announced on Tuesday, Jan. 25.According to a recent update from the Centers for Disease Control and ...
-
by
Zak Failla
Breaking News
A vaccine targeting the highly transmissible Omicron COVID-19 variant could be on the way from Pfizer.On Monday, Jan. 10, Pfizer CEO Albert Bourla said that booster targeting Omicron will be ready as soon as March, as the company has already begun ramping up production of the doses.“This vaccine will be ready in March,” Bourla told CNBC’s “Squawk Box.” “We (are) already starting ...
-
by
Zak Failla
Breaking News
As the Omicron COVID-19 variant rages across the country, federal health officials have expanded the eligibility for booster shots in younger Americans. The Food and Drug Administration (FDA) announced on Monday, Jan. 3 that it is expanding the eligibility for Pfizer and BioNTech booster shots to American between the ages of 12 and 15 years old as children return to school amid a surge ...
-
by
Zak Failla
Breaking News
For the second time in as many days, the Food and Drug Administration (FDA) has authorized the use of an antiviral pill to treat mild and moderate COVID-19 cases.On Thursday, Dec. 23, the FDA approved the use of Merck’s molnupiravir pill for emergency use authorization, a day after officials authorized the use of Pfizer’s COVID-19 treatment pill.Earlier story - COVID-19: FDA OKs First ...
-
by
Zak Failla
Breaking News
The fight against COVID-19 took a step forward as federal health officials authorized the first pill that Americans will be able to take at home to head off the worst effects of the virus.On Wednesday, Dec. 22, the US Food and Drug Administration (FDA) granted emergency authorization for Pfizer’s COVID-19 treatment pill, which has been recommended for people at high risk of developing ...